Diabetes, Obesity and Metabolism, 24 (8), 1553-1564
These drugs help reduce food intake and promote weight loss, providing an effective therapeutic option for individuals struggling with obesity
Unlike berberine, which supports existing metabolic pathways, GLP-1 drugs directly stimulate receptor activity to trigger appetite suppression, increase insulin secretion, and slow gastric emptying
Comparatively, orforglipron, Lillys oral nonpeptide GLP-1, reported dysesthesia in only 1.2% of participants at the highest dose
Many compounding pharmacies create versions of these drugs that may not meet the same safety and quality standards as FDA-approved products
However, it has been associated with several negative side effects, including: Gastrointestinal issues such as nausea, vomiting, and diarrhea Pancreatitis Thyroid tumors Hypoglycemia (low blood sugar) Wegovy (semaglutide) Wegovy is a popular weight loss drug that has recently come under scrutiny due to its adverse effects